Results of a comparative study of the antiarrhythmic activity of liposomal forms of lappaconitine hydrobromide (LH) and its complex with the monoammonium salt of glycyrrhizic acid (MASGA) in the aconitine arrhythmia model (pathognomonic for class I antiarrhythmic drugs according to the VaughnWilliams classification) and the antiarrhythmic drug Allapinin® (lappaconitine hydrobromide) are presented. The liposomal form of LH/MASGA with a LH concentration of 1 ìg/mL is shown to restore effectively the contractile activity of papillary muscle. Moreover, the restored contractile activity persists for a longer time without arrhythmia recurrence than is observed for Allapinin, where arrhythmia recurred after 90 min. It is assumed that the liposomal form of LH/MASGA may become a promising antiarrhythmic drug because of a marked decrease in the toxic effect and a pronounced trend toward a decrease in the time required to restore heart rhythm without arrhythmia recurrence.
Similar content being viewed by others
References
A. L. Syrkin and A. V. Dobrovol’skii, Consilium Medicum, 10, 492 – 496 (2001).
A. N. Okorokov, Diagnosis of Internal Organ Diseases [in Russian], Vol. 7, Moscow (2006).
J. Constant, Bedside Cardiology, Lippincott Williams & Wilkins, Philadelphia (1999) [Russian translation, Moscow (2004)].
P. Kh. Dzhanashiya, N. M. Shevchenko, et al., Serdtse: Zh. Prakt. Vrachei, 2(2), 97 – 99 (2002).
Yu. N. Belenkov and V. Yu. Mareev, Serdechno-Sosud. Nedostatochn., 1(3), 7 – 11 (2002).
B. Ya. Bart, O. L. Smirnova, V. G. Larin, and L. A. Morozovskaya, Kardiologiya, 3(37), 33 – 36 (1997).
V. D. Vakhlyaev, A. V. Nedostup, D. A. Tsaregorodtsev, and M. Yu. Mazing, Ross. Med. Zh., 2, 54 – 56 (2000).
G. M. Solov’yan and T. V. Mikhaleva, Ukr. Kardiol. Zh., 2(26), 76 – 90 (2019).
E. I. Chazov, Serdtse: Zh. Prakt. Vrachei, 1(1), 6 – 8 (2002).
M. Akhtar, H. Garan, M. H. Lehmann, et al., Ann. Intern. Med., 114(6), 499 – 512 (1991).
B. M. Altura, Magnesium Trace Elem., 167 – 171 (1991).
S. F. Sokolov, Vestn. Aritmol., 64, 60 – 70 (2011).
A. A. Kotlyarov, O. A. Dmitrieva, L. M. Mosina, and T. N. Karyakina, Klin. Med., No. 9, 57 – 59 (2012).
S. G. Kanorskii, Kardiologiya, 54(2), 60 – 65 (2014).
Yu. N. Zamotaev, Yu. A. Kremnev, N. A. Grinenko, and S. E. Podshibyakin, Russ. Med. Zh., No. 9, 518 (2003).
V. V. Plechev, Sh. Z. Zagidullin, V. M. Yunusov, et al., Kardiologiya, 53(8), 34 – 39 (2013).
D. P. Zipes, A. J. Camm, M. Borggrefe, et al., Circulation, 114, e385-e484 (2006).
S. F. Sokolov, M. M. Belyaeva, et al., Kardiologiya, 57(4), 45 – 52 (2017).
F. N. Dzhakhangirov and S. F. Sokolov, New Antiarrhythmic Medicine Allapinin (Pharmacology and Clinical Use), Tashkent (2004).
Zh. F. Ziyavitdinov, U. Zh. Ishimov, N. Sh. Berdiev, et al., Khim.-farm. Zh., 56(2), 25 – 32 (2022); Pharm. Chem. J., 56(2), 167 – 173 (2022).
V. V. Uzbekov, B. F. Abdullaev, Yu. I. Oshchepkova, and Sh. I. Salikhov, Vestn. Farm., 3(85), 94 – 101 (2019).
European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes; http://www.lawmix.ru/abro.php?id=11036.
N. V. Kaverina, Kardiologiya, 26(8), 59 – 63 (1986).
M. M. Musaev, P. B. Usmanov, et al., Computer program “Analysis of the kinetics of muscle contraction”: State Patent Office of the RUz. Certificate No. DGU 01873. Dec. 18, 2009 / Official Bulletin, 1(9), 170 – 171.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 56, No. 10, pp. 23 – 29, October, 2022.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Uzbekov, V.V., Abdullaev, B.F., Jumayev, I.Z. et al. Comparative Study of the Antiarrhythmic Activity of Liposomal Forms of Lappaconitine Hydrobromide and its Complex with Glycyrrhizic Acid Monoammonium Salt in the Aconitine Arrhythmia Model. Pharm Chem J 56, 1327–1332 (2023). https://doi.org/10.1007/s11094-023-02793-5
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-023-02793-5